Press Releases

ANN ARBOR, Mich., Feb. 4, 2020 /PRNewswire/ -- Swift Biosciences, Inc ("Swift") and Helix OpCo, LLC ("Helix") today announced a Partnership Agreement to leverage Swift's 2S™ Turbo DNA library preparation for Helix's Exome+™ assay. Helix, a population genomics company, uses the Exome+™ assay to power population health prog

CINCINNATI, Feb. 4, 2020 /PRNewswire/ -- Improving sickle cell disease care in Africa. Developing new esophageal organoids. Advancing the field of circadian medicine in ways that could affect how thousands of medications are prescribed. These are just some of the many outcome-improving discoveries made by scientists at Cincinnati Childre

HOUSTON, Feb. 4, 2020 /PRNewswire/ -- Nova Medical Centers is announcing our support for Ellie Fetner, a teen-aged survivor who wants to make a difference through the Leukemia and Lymphoma Society "Students of the Year" program! 

BEIJING, Feb. 4, 2020 /PRNewswire/ -- A news report by China.org.cn on China's efforts to battle coronavirus outbreak:

BOCA RATON, Fla., Feb. 4, 2020 /PRNewswire/ -- Strengthen your heart, literally and figuratively, this February with Orangetheory Fitness® as the brand collaborates with the American Heart Association to help prospects and members live a longer, more vibrant life. As the first step of a larger initiative, Orangetheory Fitness studios across the U.S. are

MACON, Ga., Feb. 4, 2020 /PRNewswire/ -- Mariha Spencer of Warner Robins, Ga. was approximately six months pregnant with her first child, Amillia, when she learned her daughter had a rare congenital defect, known as esophageal atresia, which is characterized by an improper or absent connection between the esophagus

HOUSTON, Feb. 4, 2020 /PRNewswire/ -- The Prelude Network (Prelude), the largest provider of comprehensive fertility services in the U.S. whose commitment is to deliver the high

ABBOTT PARK, Ill., Feb. 4, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that the company has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its in-development Fully Implantable Left Ventricular Assist System (FILVAS). The FDA launched the

Senior Leadership Voluntarily Surrenders Options to Support Employees' Continued Dedication to Return to Profitability PHOENIX, Feb. 4, 2020 /PRNewswire/ -- 

DALLAS, Feb. 4, 2020 /PRNewswire/ -- GHR RevCycle Workforce, formerly the HIM Division of HCTec, has been ranked as the top performing